Cargando…
Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study
OBJECTIVE: We aimed to identify a lipidic profile associated with type 2 diabetes mellitus (T2DM) development in coronary heart disease (CHD) patients, to provide a new, highly sensitive model which could be used in clinical practice to identify patients at T2DM risk. METHODS: This study considered...
Autores principales: | Villasanta-Gonzalez, Alejandro, Mora-Ortiz, Marina, Alcala-Diaz, Juan F., Rivas-Garcia, Lorenzo, Torres-Peña, Jose D., Lopez-Bascon, Asuncion, Calderon-Santiago, Monica, Arenas-Larriva, Antonio P., Priego‑Capote, Feliciano, Malagon, Maria M., Eichelmann, Fabian, Perez-Martinez, Pablo, Delgado-Lista, Javier, Schulze, Matthias B., Camargo, Antonio, Lopez-Miranda, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401778/ https://www.ncbi.nlm.nih.gov/pubmed/37537576 http://dx.doi.org/10.1186/s12933-023-01933-1 |
Ejemplares similares
-
Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study
por: Mora-Ortiz, Marina, et al.
Publicado: (2022) -
A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study
por: Villasanta-Gonzalez, Alejandro, et al.
Publicado: (2021) -
Diet and SIRT1 Genotype Interact to Modulate Aging-Related Processes in Patients with Coronary Heart Disease: From the CORDIOPREV Study
por: Hidalgo-Moyano, Cristina, et al.
Publicado: (2022) -
Evolution of Metabolic Phenotypes of Obesity in Coronary Patients after 5 Years of Dietary Intervention: From the CORDIOPREV Study
por: Martin-Piedra, Laura, et al.
Publicado: (2021) -
Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study
por: Gutierrez-Mariscal, Francisco M., et al.
Publicado: (2023)